Press Releases
Investor Resources
Press Releases
Press Release
Cardiol Therapeutics Announces Filing of 2020 Year-end Financial Statements and MD&AApril 1, 2021
Press Release
Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical OfficerMarch 30, 2021
Press Release
Cardiol Therapeutics to Participate in Upcoming Virtual Investor ConferencesJanuary 7, 2021
Press Release
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™December 22, 2020
Press Release
Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.October 20, 2020
Press Release
Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 TrialSeptember 25, 2020